-+ 0.00%
-+ 0.00%
-+ 0.00%
Reported Earlier, Mesoblast's FDA-Approved Ryoncil Gets IND Clearance For Registrational DMD Trial, To Randomize 76 Patients Aged 5-9 Years Across 7 Infusions Over 9 Months
Share
Listen to the news

Partnering with Parent Project Muscular Dystrophy to ensure timely access to the trial for eligible patients

~15,000 children are living with DMD in the U.S.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending